These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2086222)

  • 1. Anaerobic susceptibility tests with single breakpoint concentrations.
    Barry AL
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):849-50. PubMed ID: 2086222
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to inactivating bacterial enzymes of different cephalosporins and in vitro activity.
    Ravizzola G; Manca N; Turano A
    Chemioterapia; 1984 Aug; 3(4):242-5. PubMed ID: 6532543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of selected obligate anaerobic bacteria obtained from bovine and equine sources to ceftiofur.
    Samitz EM; Jang SS; Hirsh DC
    J Vet Diagn Invest; 1996 Jan; 8(1):121-3. PubMed ID: 9026069
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic sensitivity testing of anaerobic bacteria by the breakpoint method.
    Höffler U; Pulverer G
    Chemotherapy; 1984; 30(6):392-7. PubMed ID: 6518836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of flomoxef in comparison to other cephalosporins.
    Simon C; Simon M; Plieth C
    Infection; 1988; 16(2):131-4. PubMed ID: 3372024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.
    Bansal MB; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(4):237-43. PubMed ID: 6744975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
    Pascual A; Borobio V; Garcia-Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1987 May; 19(5):701-3. PubMed ID: 3610904
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative activity of several beta-lactam antibiotics against anaerobes determined by two methods.
    Zabransky RJ; Birk RJ
    Clin Ther; 1987; 10(1):107-25. PubMed ID: 3450391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Clin Lab Med; 1989 Jun; 9(2):239-54. PubMed ID: 2659243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of selected antibiotics against anaerobes.
    Wexler HM; Finegold SM
    Clin Ther; 1987; 10 Suppl A():12-8. PubMed ID: 3690606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S).
    Ruckdeschel G; Eder W
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):687-91. PubMed ID: 3143586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):777-82. PubMed ID: 2261923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniques.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1988; 10(6):747-60. PubMed ID: 3219688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.